Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression
- PMID: 36045402
- PMCID: PMC9429363
- DOI: 10.1186/s40168-022-01337-5
Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression
Abstract
Background: Women with a cervicovaginal microbiota dominated by Lactobacillus spp. are at reduced risk of acquiring sexually transmitted infections including HIV, but the biological mechanisms involved remain poorly defined. Here, we performed metaproteomics on vaginal swab samples from young South African women (n = 113) and transcriptomics analysis of cervicovaginal epithelial cell cultures to examine the ability of lactic acid, a metabolite produced by cervicovaginal lactobacilli, to modulate genital epithelial barrier function.
Results: Compared to women with Lactobacillus-depleted microbiota, women dominated by vaginal lactobacilli exhibit higher abundance of bacterial lactate dehydrogenase, a key enzyme responsible for lactic acid production, which is independently associated with an increased abundance of epithelial barrier proteins. Physiological concentrations of lactic acid enhance epithelial cell culture barrier integrity and increase intercellular junctional molecule expression.
Conclusions: These findings reveal a novel ability of vaginal lactic acid to enhance genital epithelial barrier integrity that may help prevent invasion by sexually transmitted pathogens. Video abstract.
Keywords: Epithelial cells; Female reproductive tract; HIV; Lactic acid; Lactobacilli; Metabolites; STIs; Tight junctions; Transcriptomics; Vaginal microbiome.
© 2022. The Author(s).
Conflict of interest statement
GT and ACH are coinventors on a patent application examining the immunomodulatory effects of L-lactic acid on cervicovaginal epithelial cells. The other authors declare that they have no competing interests.
Figures







Similar articles
-
Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.Front Cell Infect Microbiol. 2020 Jan 10;9:446. doi: 10.3389/fcimb.2019.00446. eCollection 2019. Front Cell Infect Microbiol. 2020. PMID: 31998660 Free PMC article.
-
Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.mSphere. 2018 Jul 5;3(4):e00055-18. doi: 10.1128/mSphere.00055-18. mSphere. 2018. PMID: 29976641 Free PMC article.
-
The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection.mBio. 2019 Aug 13;10(4):e01548-19. doi: 10.1128/mBio.01548-19. mBio. 2019. PMID: 31409678 Free PMC article.
-
Vaginal microbiome.Ceska Gynekol. 2018 Winter;83(5):371-379. Ceska Gynekol. 2018. PMID: 30848142 Review. English.
-
The role of lactic acid production by probiotic Lactobacillus species in vaginal health.Res Microbiol. 2017 Nov-Dec;168(9-10):782-792. doi: 10.1016/j.resmic.2017.04.001. Epub 2017 Apr 20. Res Microbiol. 2017. PMID: 28435139 Review.
Cited by
-
Distinct cervical tissue-adherent and luminal microbiome communities correlate with mucosal host gene expression and protein levels in Kenyan sex workers.Microbiome. 2023 Mar 31;11(1):67. doi: 10.1186/s40168-023-01502-4. Microbiome. 2023. PMID: 37004130 Free PMC article.
-
Uterine Microbiota and Bisphenols: Novel Influencers in Reproductive Health.J Xenobiot. 2025 Feb 2;15(1):26. doi: 10.3390/jox15010026. J Xenobiot. 2025. PMID: 39997369 Free PMC article. Review.
-
Maternal intestinal L. vaginalis facilitates embryo implantation and survival through enhancing uterine receptivity in sows.Microbiome. 2025 Jun 18;13(1):145. doi: 10.1186/s40168-025-02141-7. Microbiome. 2025. PMID: 40533850 Free PMC article.
-
MetaNovo: An open-source pipeline for probabilistic peptide discovery in complex metaproteomic datasets.PLoS Comput Biol. 2023 Jun 16;19(6):e1011163. doi: 10.1371/journal.pcbi.1011163. eCollection 2023 Jun. PLoS Comput Biol. 2023. PMID: 37327214 Free PMC article.
-
The human vaginal microbiota: from clinical medicine to models to mechanisms.Curr Opin Microbiol. 2024 Feb;77:102422. doi: 10.1016/j.mib.2023.102422. Epub 2024 Jan 11. Curr Opin Microbiol. 2024. PMID: 38215548 Free PMC article. Review.
References
-
- Fettweis JM, Brooks JP, Serrano MG, Sheth NU, Girerd PH, Edwards DJ, The Vaginal Microbiome Consortium. Jefferson KK, Buck GA, et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology (Reading) 2014;160(Pt 10):2272–2282. doi: 10.1099/mic.0.081034-0. - DOI - PMC - PubMed
-
- Aldunate M, Srbinovski D, Hearps AC, Latham CF, Ramsland PA, Gugasyan R, et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol. 2015;6:164. doi: 10.3389/fphys.2015.00164. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous